Skomedal et al. found TP53 alterations in 50% of primary vaginal carcinomas [98], whereas Lee et al. noted that TP53 mutations are rare in mesonephric adenocarcinomas [4]. The gene discussed is TP53; the disease is mesonephric adenocarcinoma.